ArticleEBioMedicine2019

Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.

Cora Blázquez-Bermejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.